✦ LIBER ✦

Chemotherapy of advanced breast cancer: A randomized trial of vincristine, adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP)

✍ Scribed by J. Carmo-Pereira; F. Oliveira Costa; Elvira Henriques

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 402 KB
Volume: 48
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19811001)48:7<1517::aid-cncr2820480707>3.0.co;2-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide versus cyclophosphamide

Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: A randomized trial

✍ Hyman B. Muss; Virginia Howard; Frederick Richards Ii; Douglas R. White; Don V. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

Thirty-two evaluable patients with metastatic carcinoma of the prostate were entered into a prospective randomized trial comparing cyclophosphamide (CYC) with a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF). Progressive disease after endocrine manipulation was noted in 97% (3

Correlation of estrogen receptors and re

Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in advanced breast cancer

✍ Jae C. Chang; Gilbert Wergowske 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

Adjuvant doxorubicin and cyclophosphamid

Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma : Results of a randomized controlled trial

✍ Soo-Mee Bang; Dae Seog Heo; Ki Hyeong Lee; Jae Ho Byun; Heung Moon Chang; Dong-Y 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Cyclophosphamide (NSC 26271) versus the

Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial

✍ Rowan T. Chlebowski; Robert Hestorff; Leonard Sardoff; John Weiner; Joseph R. Ba 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views

Mitoxantrone, 5-fluorouracil, and high d

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma : A randomized Phase II trial

✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding

A prospective, randomized phase III tria

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w